Psychiatric Times
Vol 40, Issue 8
Vol 40, Issue 7
Vol 40, Issue 6
Vol 40, Issue 5
Vol 40, Issue 4
Vol 40, Issue 3
Vol 40, Issue 2
Vol 40, Issue 1
Vol 39, Issue 12
Vol 39, Issue 11
Vol 39, Issue 10
Vol 39, Issue 9
Volume 39, Issue 9 Psychedelics Supplement
Vol 39, Issue 8
Vol 39, Issue 7
Vol 39, Issue 6
Vol 39, Issue 5
Vol 39, Issue 4
Vol 39, Issue 3
Vol 39, Issue 2
Vol 39, Issue 1
Vol 38, Issue 12 Sleep Supplement
Vol 38, Issue 12
Vol 38, Issue 11
Vol 38, Issue 10
Vol 38, Issue 9
Vol 38, Issue 8 Digital Supplement
Vol 38, Issue 8
Vol 38, Issue 7
Vol 38, Issue 6
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves ProlivRX: First Prescription, Physician-Directed, At-Home Brain Neuromodulation Therapy for MDD
2
What Makes It So Special? A Review of the Mechanisms of Action of Lamotrigine, Carbamazepine, and Valproic Acid and How They Differ From Other Antiepileptics
3
Anticholinergic Burden and Its Effect on Cognition in Psychosis
4
The Impact of Gender Roles on Psychiatric Treatment: In Conversation With Eugene T. Lucas Jr, DNP, CRNP, FNP-BC, APMHNP-BC
5